You are here: Industry Insights > COVID-19

News List

'Own' immune cells to target infectious diseases including COVID-19 worldpharmanews
April 26, 2020
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS).
AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients worldpharmanews
April 26, 2020
AstraZeneca and Saint Luke's Mid America Heart Institute have initiated a randomised, global Phase III trial to assess the potential of Farxiga (dapagliflozin).
Key nose cells identified as likely COVID-19 virus entry points worldpharmanews
April 26, 2020
Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to g
FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs worldpharmanews
April 26, 2020
The U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems.
HVP Launches Global Initiative to Accelerate the Development of COVID-19 Vaccines americanpharmaceuticalreview
April 26, 2020
The Human Vaccines Project (HVP), a global nonprofit consortium, is launching the COVID Vaccine Initiative (CVI) to develop safe, effective, accessible vaccines for those most vulnerable to COVID-19.
CMIC Supports Avigan Production for Potential COVID-19 Treatment contractpharma
April 26, 2020
Includes clinical trials and manufacturing of influenza antiviral drug for COVID-19 patients.
FDA Cautions Use of Hydroxychloroquine, Chloroquine for COVID-19 Outside Hospital Due americanpharmaceuticalrevie
April 26, 2020
The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines. We are also aware of increased use of these me
Cytovance and Akshaya Enter Vaccine Collaboration contractpharma
April 26, 2020
Partnership to focus on therapeutics for treatment of coronavirus and hepatitis B virus infections.
Gilead says leaked Covid-19 trial data of remdesivir inconclusive Pharmaceutical-Technology.
April 26, 2020
Gilead’s remdesivir has failed to show benefit in a clinical trial conducted to treat Covid-19 patients in China, according to data the World Health Organization (WHO) accidentally posted on its website.
J&J selects Emergent BioSolutions for Covid-19 vaccine manufacturing pharmaceutical-technology
April 26, 2020
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has signed an agreement with Emergent BioSolutions for manufacturing services for its lead investigational Covid-19 vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page